Axiom/Review & Extract
+ New intake
← Review & Extract

Review findings

57 finding(s) · status completed · 2026-06-15 21:42

completed
Review before activation. Approving creates a source-backed record (asset, dosing reference, or evidence claim). Rejected findings are discarded. Findings you have not approved never reach the Clinical Assistant or protocol builder.
Candidate assets
27
  • KPVconf 90%pending

    Restore access No thanks, continue reading Related Reading Peptide BPC-157 body protection compound peptide Peptide Thymosin Alpha-1 immune modulating peptide Peptide Glutathione peptide How KPV works at the cellular level Overview of KPV benefits and applications Scientific Details Molecular Formula C16H30N4O4 Molecular Weight 342.4 Da CAS Number 67727-97-3 Sequence Lys-Pro-Val What is KPV? # KPV is a naturally occurring tripeptide consisting of the amino acids lysine, proline, and valine (Lys-Pro-Val), corresponding to positions 11-13 at the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH).

  • KPVconf 90%pending

    KPV Peptide: Anti-Inflammatory Tripeptide Guide | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?

  • KPVconf 90%pending

    de effects of KPV?

  • BPC-157conf 90%pending

    Restore access No thanks, continue reading Related Reading Peptide BPC-157 body protection compound peptide Peptide Thymosin Alpha-1 immune modulating peptide Peptide Glutathione peptide How KPV works at the cellular level Overview of KPV benefits and applications Scientific Details Molecular Formula C16H30N4O4 Molecular Weight 342.4 Da CAS Number 67727-97-3 Sequence Lys-Pro-Val What is KPV? # KPV is a naturally occurring tripeptide consisting of the amino acids lysine, proline, and valine (Lys-Pro-Val), corresponding to positions 11-13 at the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH).

  • LL-37conf 90%pending

    Immune Support Healing & Tissue Repair LL-37 LL-37: Human cathelicidin antimicrobial peptide guide.

  • KPVconf 90%pending

    gues established that the minimal anti-inflammatory sequence of alpha-MSH could be narrowed to the C-terminal tripeptide KPV.

  • KPVconf 90%pending

    (1999) showed that KPV inhibits the activation of the IKK complex, thereby preventing phosphorylation and degradation of IkB-alpha.

  • KPVconf 90%pending

    Studies have demonstrated that KPV can even enter the cell nucleus, where it may directly interfere with NF-kB binding to DNA promoter elements.

  • KPVconf 90%pending

    Preclinical Evidence # Colitis Models # The most developed preclinical evidence for KPV pertains to its efficacy in experimental models of inflammatory bowel disease.

  • KPVconf 90%pending

    this formulation improved colonic delivery and enhanced therapeutic efficacy in the DSS colitis model compared to free KPV.

  • KPVconf 90%pending

    Beyond IBD, KPV is under investigation for other conditions characterized by mucosal inflammation, including pouchitis (inflammation of the ileal pouch following colectomy for ulcerative colitis) and radiation proctitis.

  • KPVconf 90%pending

    The pharmacokinetics of KPV in humans are not characterized.

  • KPVconf 90%pending

    The relative potency of KPV compared to established anti-inflammatory biologics (anti-TNF antibodies, anti-integrin antibodies, JAK inhibitors) in the context of human IBD is entirely unknown.

  • LL-37conf 90%pending

    KPV inhibits IKK complex activation Prevents phosphorylation and degradation of IkB-alpha Blocks NF-kB nuclear translocation Related Reading # KPV research studies and evidence KPV dosing protocols KPV side effects profile Glutathione research guide LL-37 research guide Stay current on K

  • KPVconf 90%pending

    role of PepT1 in KPV-mediated anti-inflammatory effects, demonstrating that PepT1 silencing abolishes KPV's protective effects in colitis models.

  • KPVconf 90%pending

    Based on 40 + community reports View community protocols Frequently Asked Questions About KPV What is KPV?

  • KPVconf 90%pending

    Report an Error Compare KPV with Other Peptides KPV vs Larazotide KPV and Larazotide target gut barrier health through fundamentally different mechanisms: KPV suppresses the inflammatory signaling (NF-kB) that damages the gut barrier, while Larazotide directly stabilizes tight junctions by blocking zonulin-mediated permeability.

  • AOD-9604conf 90%pending

    Peptide Protocol Wiki March 30, 2026 BPC-157 Thymosin Alpha-1 AOD-9604 + 16 more Guide 18 min read Most Popular Therapeutic Peptides in 2026: 15 Ranked by Research Interest The 15 most popular therapeutic peptides in 2026, ranked by clinical trial activity, search interest, and research community adoption.

  • BPC-157conf 90%pending

    Peptide Protocol Wiki March 30, 2026 BPC-157 Thymosin Alpha-1 AOD-9604 + 16 more Guide 18 min read Most Popular Therapeutic Peptides in 2026: 15 Ranked by Research Interest The 15 most popular therapeutic peptides in 2026, ranked by clinical trial activity, search interest, and research community adoption.

  • LL-37conf 90%pending

    Their mechanisms are complementary rather than competing -- one addresses the inflammatory trigger while the other reinforces the structural barrier. → KPV vs LL-37 LL-37 has a broader and more developed research base as the only human cathelicidin antimicrobial peptide, with direct pathogen-killing capabilities and extensive mechanistic data across multiple therapeutic areas.

  • KPVconf 90%pending

    Their mechanisms are complementary rather than competing -- one addresses the inflammatory trigger while the other reinforces the structural barrier. → KPV vs LL-37 LL-37 has a broader and more developed research base as the only human cathelicidin antimicrobial peptide, with direct pathogen-killing capabilities and extensive mechanistic data across multiple therapeutic areas.

  • Tesamorelinconf 90%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • Ipamorelinconf 90%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • BPC-157conf 90%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • LL-37conf 90%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • KPVconf 90%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • VIPconf 90%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

Candidate dosing
1
  • conf 66%pending

    nflammatory effects for gut health (IBD/colitis) and immune modulation 💉 Dosing Amount 200-500 mcg per injection (SC); or oral capsules as directed Frequency Once daily (SC);

    dose: 500 mcg · route: oral · frequency: Once daily

Candidate safety
8
  • KPVconf 60%pending

    Browse all immune peptides → Table of Contents 📌 TL;DR • Potent anti-inflammatory activity without melanocortin receptor binding • Inhibits NF-kB nuclear translocation • Investigated for inflammatory bowel disease • Crosses cell membranes and enters the nucleus Community-Reported Side Effects Anecdotal ? 📋 Protocol Quick-Reference Anti-i

  • LL-37conf 60%pending

    KPV inhibits IKK complex activation Prevents phosphorylation and degradation of IkB-alpha Blocks NF-kB nuclear translocation Related Reading # KPV research studies and evidence KPV dosing protocols KPV side effects profile Glutathione research guide LL-37 research guide Stay current on K

  • KPVconf 60%pending

    KPV Peptide: Anti-Inflammatory Tripeptide Guide | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?

  • KPVconf 60%pending

    Start the 7-step beginner guide Peptides Side Effects New Directory Learn Tools Blog News About KPV 📋 Overview 🧬 Molecule 🔄 Similar ⚠️ Side Effects 💉 Dosing 🔬 Research 🚨 Risks 👥 Community 📊 Community Data Home Peptides KPV Immune Support Healing & Tissue Repair preclinical KPV Also known as: Lys-Pro-Val, Alpha-MSH C-terminal tripeptide, KPV tripeptide Compare with 2 peptide s Research compiled by Peptide Protocol Wiki 📅 Updated January 29, 2026 Citations Verified TL;DR KPV is a naturally occurring anti-inflammatory tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-MSH.

  • KPVconf 60%pending

    Reported side effects of KPV include gastrointestinal discomfort.

  • LL-37conf 60%pending

    Most reported side effects are mild and transient.

  • LL-37conf 60%pending

    Consult the detailed side effects profile for full information.

  • conf 60%pending

    Peptide Directory All Peptides Metabolic Anti-Obesity Anti-Aging Immune Hormonal View All Categories Directory Peptide Vendors Analytics Labs Side Effects Database Report a Side Effect Learn Start Here What Are Peptides?

Candidate monitoring
2
  • KPVconf 60%pending

    Larazotide has a vastly stronger evidence base, with Phase 3 clinical data for celiac disease, FDA Fast Track designation, and safety data from 800+ patients.

  • conf 60%pending

    1-2 times daily (oral) Timing No specific timing requirement; oral doses on empty stomach may improve absorption 📅 Cycle Duration 4-8 weeks, or longer for chronic conditions Repeatable Yes Preparation & Storage Diluent: Bacteriostatic water ⚗️ Suggested Bloodwork ( 6 tests) CRP and ESR When: Baseline Why: Baseline inflammatory markers CBC with differential When: Baseline Why: Baseline immune cell counts CMP with liver enzymes When: Baseline Why: Baseline metabolic function Fecal calprotectin (if IBD) When: Baseline Why: Baseline intestinal inflammation marker CRP When: 4 weeks Why: Monitor inflammatory marker response Fecal calprotectin (if IBD) When: 4-6 weeks Why: Assess gut inflammation improvement 💡 Key Considerations → Its small size makes it a PepT1 transporter substrate, allowing direct intestinal epithelial uptake when taken orally → Contraindication: No formal contraindications established; use cautiously in immunocompromised patients Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

Candidate contraindications
2
  • LL-37conf 70%pending

    Peptide Protocol Wiki February 17, 2026 Thymosin Alpha-1 KPV LL-37 + 3 more Research Review 11 min read The Science of Peptide Stacking: Synergies, Risks, and Evidence A research-focused examination of peptide stacking science, covering synergistic mechanisms, evidence-based stacks, theoretical combinations, contraindicated pairings, and the gap between community protocols and published research.

  • conf 70%pending

    1-2 times daily (oral) Timing No specific timing requirement; oral doses on empty stomach may improve absorption 📅 Cycle Duration 4-8 weeks, or longer for chronic conditions Repeatable Yes Preparation & Storage Diluent: Bacteriostatic water ⚗️ Suggested Bloodwork ( 6 tests) CRP and ESR When: Baseline Why: Baseline inflammatory markers CBC with differential When: Baseline Why: Baseline immune cell counts CMP with liver enzymes When: Baseline Why: Baseline metabolic function Fecal calprotectin (if IBD) When: Baseline Why: Baseline intestinal inflammation marker CRP When: 4 weeks Why: Monitor inflammatory marker response Fecal calprotectin (if IBD) When: 4-6 weeks Why: Assess gut inflammation improvement 💡 Key Considerations → Its small size makes it a PepT1 transporter substrate, allowing direct intestinal epithelial uptake when taken orally → Contraindication: No formal contraindications established; use cautiously in immunocompromised patients Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.

Candidate synergies
17
  • LL-37 + KPVconf 70%pending

    Peptide Protocol Wiki February 17, 2026 Thymosin Alpha-1 KPV LL-37 + 3 more Research Review 11 min read The Science of Peptide Stacking: Synergies, Risks, and Evidence A research-focused examination of peptide stacking science, covering synergistic mechanisms, evidence-based stacks, theoretical combinations, contraindicated pairings, and the gap between community protocols and published research.

  • LL-37 + KPVconf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • Tesamorelin + KPVconf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • Tesamorelin + VIPconf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • Ipamorelin + BPC-157conf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • BPC-157 + KPVconf 50%pending

    Restore access No thanks, continue reading Related Reading Peptide BPC-157 body protection compound peptide Peptide Thymosin Alpha-1 immune modulating peptide Peptide Glutathione peptide How KPV works at the cellular level Overview of KPV benefits and applications Scientific Details Molecular Formula C16H30N4O4 Molecular Weight 342.4 Da CAS Number 67727-97-3 Sequence Lys-Pro-Val What is KPV? # KPV is a naturally occurring tripeptide consisting of the amino acids lysine, proline, and valine (Lys-Pro-Val), corresponding to positions 11-13 at the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH).

  • LL-37 + KPVconf 50%pending

    Their mechanisms are complementary rather than competing -- one addresses the inflammatory trigger while the other reinforces the structural barrier. → KPV vs LL-37 LL-37 has a broader and more developed research base as the only human cathelicidin antimicrobial peptide, with direct pathogen-killing capabilities and extensive mechanistic data across multiple therapeutic areas.

  • AOD-9604 + BPC-157conf 50%pending

    Peptide Protocol Wiki March 30, 2026 BPC-157 Thymosin Alpha-1 AOD-9604 + 16 more Guide 18 min read Most Popular Therapeutic Peptides in 2026: 15 Ranked by Research Interest The 15 most popular therapeutic peptides in 2026, ranked by clinical trial activity, search interest, and research community adoption.

  • Ipamorelin + LL-37conf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • Ipamorelin + KPVconf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • BPC-157 + LL-37conf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • BPC-157 + KPVconf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • KPV + VIPconf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • LL-37 + VIPconf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.

  • LL-37 + KPVconf 50%pending

    Peptide Protocol Wiki February 17, 2026 BPC-157 TB-500 Ipamorelin + 5 more You Might Also Like Related content you may find interesting Peptide Immune LL-37 Peptide Immune Larazotide Peptide Immune Glutathione Peptide Immune Motixafortide Table of Contents What is KPV?

  • LL-37 + KPVconf 50%pending

    KPV inhibits IKK complex activation Prevents phosphorylation and degradation of IkB-alpha Blocks NF-kB nuclear translocation Related Reading # KPV research studies and evidence KPV dosing protocols KPV side effects profile Glutathione research guide LL-37 research guide Stay current on K

  • Tesamorelin + LL-37conf 50%pending

    elin Retatrutide Tesamorelin + 12 more Research Review 12 min read Immune-Modulating Peptides: Thymosin Alpha-1, KPV, LL-37, and Beyond Comprehensive research review of immune-modulating peptides including thymosin alpha-1, KPV, LL-37, thymalin, VIP, and glutathione.